Protagenic Therapeutics, Inc. Enters into Amendment No. 1 to At Market Issuance Sales Agreement
On January 9, 2025, Protagenic Therapeutics, Inc. announced that it has entered into Amendment No. 1 to the At Market Issuance Sales Agreement with B. Riley Securities, Inc. The Sales Agreement, dated July 2, 2021, enables the company to offer and sell shares of its common stock through the Agent, with an aggregate offering price […]
More Stories
InZinc Mining (CVE:IZN) Reaches New 1-Year Low – Here’s Why
InZinc Mining Ltd. (CVE:IZN – Get Free Report)’s share price hit a new 52-week low during trading on Tuesday ....
Credit Suisse High Yield Bond Fund, Inc. (NYSEAMERICAN:DHY) Insider Acquires $120,986.13 in Stock
Credit Suisse High Yield Bond Fund, Inc. (NYSEAMERICAN:DHY – Get Free Report) insider Laura A. Defelice acquired 56,801 shares of...
Progress Software (NASDAQ:PRGS) Releases Q1 Earnings Guidance
Progress Software (NASDAQ:PRGS – Get Free Report) issued an update on its first quarter earnings guidance on Tuesday morning. The...
Agilysys (NASDAQ:AGYS) Posts Quarterly Earnings Results, Beats Estimates By $0.04 EPS
Agilysys (NASDAQ:AGYS – Get Free Report) released its quarterly earnings data on Tuesday. The software maker reported $0.38 EPS for...
Grid Metals (CVE:GRDM) Trading Up 33.3% – Here’s What Happened
Shares of Grid Metals Corp. (CVE:GRDM – Get Free Report) shot up 33.3% during trading on Tuesday . The stock...
Empresa Distribuidora y Comercializadora Norte Sociedad Anónima (NYSE:EDN) Stock Price Up 8.8% – Time to Buy?
Empresa Distribuidora y Comercializadora Norte Sociedad Anónima (NYSE:EDN – Get Free Report) shot up 8.8% during mid-day trading on Tuesday...